FATE - Fate Therapeutics Inc. (FATE) CEO Scott Wolchko on Q1 2020 Results - Earnings Call Transcript
Fate Therapeutics, Inc. (FATE)
Q1 2020 Earnings Conference Call
May 11, 2020 5:00 PM ET
Company Participants
Scott Wolchko - President & Chief Executive Officer
Wayne Chu - Senior Vice President, Clinical Development
Conference Call Participants
Ted Tenthoff - Piper Sandler
Robyn Karnauskas - SunTrust Robinson
Jim Birchenough - Wells Fargo
Alethia Young - Cantor
Daina Graybosch - SVB Leerink
David Nierengarten - Wedbush Securities
Biren Amin - Jefferies
Mara Goldstein - Mizuho
Ben Burnett - Stifel
Michael Schmidt - Guggenheim
Peter Lawson - Barclays
Presentation
Operator
Welcome to the Fate Therapeutics' First Quarter 2020